(Q48609932)

13 February 2018

title

Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial. (English)

1 reference

13 February 2018

1 reference

2

1 reference

13 February 2018

author name string

Sang-Do Lee

1

1 reference

13 February 2018

Aziah A Mahayiddin

3

1 reference

13 February 2018

Camilo C Roa

4

1 reference

13 February 2018

Kheng Hoe Kwa

5

1 reference

13 February 2018

Udo-Michael Goehring

6

1 reference

13 February 2018

Dirk Bredenbröker

7

1 reference

13 February 2018

Han-Pin Kuo

8

1 reference

13 February 2018

publication date

1 November 2011

1 reference

13 February 2018

published in

Respirology

1 reference

13 February 2018

volume

16

1 reference

13 February 2018

issue

8

1 reference

13 February 2018

page(s)

1249-1257

1 reference

13 February 2018

COPD in Japan: the Nippon COPD Epidemiology study

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Prevalence and risks of chronic airway obstruction: a population cohort study in taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

COPD in Asia: where East meets West

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Frontrunners in novel pharmacotherapy of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Phosphodiesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

PDE4 inhibitors: a review of current developments (2005 - 2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast: systemic therapy for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

Roflumilast with long-acting 2-agonists for COPD: influence of exacerbation history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2011.02038.X

10.1111/J.1440-1843.2011.02038.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

release_do2xs2ottfc5xgt6sts6aotqdm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/do2xs2ottfc5xgt6sts6aotqdm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21848706

1 reference

13 February 2018